The purpose of the study is to determine adverse events rates of nebulized albuterol versus
levalbuterol among adult critically ill patients and determine if a differential exists in
adverse events between the two drugs.
Phase:
Phase 4
Details
Lead Sponsor:
Fahim Khorfan, MD
Collaborators:
Ascension Genesys Hospital Genesys Regional Medical Center